Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Debt / NOTE 1.875% 4/2
-
Market price (% of par)
-
672.08%
-
Total 13F principal
-
$31,420,000
-
Principal change
-
-$230,000
-
Total reported market value
-
$210,856,000
-
Number of holders
-
8
-
Value change
-
-$1,412,000
-
Number of sells
-
1
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.875% 4/2 as of Q2 2015
As of 30 Jun 2015,
BIOMARIN PHARMACEUTICAL INC - NOTE 1.875% 4/2 was held by
8 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$31,420,000
in principal (par value) of the bond.
The largest 8 bondholders included
BAKER BROS. ADVISORS LP, Amici Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, ROYAL BANK OF CANADA, and BANK OF MONTREAL /CAN/.
This page lists
8
institutional bondholders reporting positions
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.